Indefinite Delivery Contract SPE2DX15D9303

The Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, awarded an Indefinite Delivery Contract (IDC) valued up to $4,999,999 through December 2025 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. This single-award IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide.

Under this contract, DMS Pharmaceutical Group has received numerous delivery orders to provide a variety of pharmaceutical products such as contraceptives (Nexplanon, Mirena), multiple sclerosis treatments (Aubagio), and other specialty medications and medical supplies (Surgilube lubricant) to the DLA's Medical Supply Chain division. These delivery orders, which do not have set-aside designations, allow DMS Pharmaceutical Group to leverage its status as a woman-owned small business to serve as a prime contractor supplying essential pharmaceuticals and medical equipment to support the Department of Defense's healthcare operations.